secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2021-10-29T23:59:59+00:00
Accession:  0001564590-21-052943
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kintara SVP Business Development John Liatos departs; separation terms include $226,667 severance
--------------------------------------------------------------------------------

- John Liatos stepped down as SVP Business Development effective Oct 25, 2021 to pursue other opportunities.
- Separation agreement: 8 months base salary ($226,667), COBRA reimbursement for up to 8 months.
- Stock options: additional 6 months vesting credit; vested options exercisable for 12 months post-termination.
- Non-compete and non-solicitation provisions apply for 12 months following termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000156459021052943/0001564590-21-052943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000156459021052943/ktra-8k_20211025.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-052943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer